Ocera Therapeutics, Inc. (OCRX): Venrock Healthcare Capital Patners Snapping Up Shares

Page 12 of 18

Page 12 of 18 SEC Filing
CUSIP No. 67552A108
 Page 12 of 18
 
(iii)
Sole power to dispose or to direct the disposition of
 
         
Venrock Healthcare Capital Partners, L.P.
   
0
  
VHCP Co-Investment Holdings, LLC
   
0
  
Venrock Healthcare Capital Partners II, L.P.
   
0
  
VHCP Co-Investment Holdings II, LLC
   
0
  
VHCP Management, LLC
   
0
  
VHCP Management II, LLC
   
0
  
Anders Hove
   
0
  
Bong Koh
   
0
  
 
 
(iv)
Shared power to dispose or to direct the disposition of
 
         
Venrock Healthcare Capital Partners, L.P.
   
1,885,668
(1)
VHCP Co-Investment Holdings, LLC
   
1,885,668
(1)
Venrock Healthcare Capital Partners II, L.P.
   
1,885,668
(1) 
VHCP Co-Investment Holdings II, LLC
   
1,885,668
(1)
VHCP Management, LLC
   
1,885,668
(1)
VHCP Management II, LLC
   
1,885,668
(1)
Anders Hove
   
1,885,668
(1)
Bong Koh
   
1,885,668
(1)
 
(1)
These shares are owned directly as follows: (i) 792,351 shares of common stock are owned by VHCP, including 118,981 shares underlying immediately exercisable warrants; (ii) 144,945 shares of common stock are owned by VHCP Co-Investment, including 21,765 shares underlying immediately exercisable warrants; (iii) 674,803 shares of common stock are owned by VHCP II; and (iv) 273,569 shares of common stock are owned by VHCP Co-Investment II.  VHCP Management is the general partner of VHCP and the manager of VHCP Co-Investment. VHCP Management II is the general partner of VHCP II and the manager of VHCP Co-Investment II. Messrs. Hove and Koh are the managing members of VHCP Management and VHCP Management II.
 
Item 5.
Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not Applicable
 
Item 8.
Identification and Classification of Members of the Group
Not Applicable

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)

Page 12 of 18